Management of Pregnant Inflammatory Bowel Disease Patients During the COVID-19 Pandemic

The rapid emergence of the novel coronavirus [SARS-CoV2] and the coronavirus disease 2019 [COVID-19] has caused significant global morbidity and mortality. This is particularly concerning for vulnerable groups such as pregnant women with inflammatory bowel disease [IBD]. Care for pregnant IBD patien...

Descripción completa

Detalles Bibliográficos
Autores principales: De Lima-Karagiannis, A, Juillerat, P, Sebastian, S, Pedersen, N, Bar-Gil Shitrit, A, van der Woude, C J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Supplement Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665400/
https://www.ncbi.nlm.nih.gov/pubmed/33085970
http://dx.doi.org/10.1093/ecco-jcc/jjaa125
_version_ 1783609993533063168
author De Lima-Karagiannis, A
Juillerat, P
Sebastian, S
Pedersen, N
Bar-Gil Shitrit, A
van der Woude, C J
author_facet De Lima-Karagiannis, A
Juillerat, P
Sebastian, S
Pedersen, N
Bar-Gil Shitrit, A
van der Woude, C J
author_sort De Lima-Karagiannis, A
collection PubMed
description The rapid emergence of the novel coronavirus [SARS-CoV2] and the coronavirus disease 2019 [COVID-19] has caused significant global morbidity and mortality. This is particularly concerning for vulnerable groups such as pregnant women with inflammatory bowel disease [IBD]. Care for pregnant IBD patients in itself is a complex issue because of the delicate balance between controlling maternal IBD as well as promoting the health of the unborn child. This often requires continued immunosuppressive maintenance medication or the introduction of new IBD medication during pregnancy. The current global COVID-19 pandemic creates an additional challenge in the management of pregnant IBD patients. In this paper we aimed to answer relevant questions that can be encountered in daily clinical practice when caring for pregnant women with IBD during the current COVID-19 pandemic. PODCAST: This article has an associated podcast which can be accessed at https://academic.oup.com/ecco-jcc/pages/podcast
format Online
Article
Text
id pubmed-7665400
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-76654002020-11-16 Management of Pregnant Inflammatory Bowel Disease Patients During the COVID-19 Pandemic De Lima-Karagiannis, A Juillerat, P Sebastian, S Pedersen, N Bar-Gil Shitrit, A van der Woude, C J J Crohns Colitis Supplement Articles The rapid emergence of the novel coronavirus [SARS-CoV2] and the coronavirus disease 2019 [COVID-19] has caused significant global morbidity and mortality. This is particularly concerning for vulnerable groups such as pregnant women with inflammatory bowel disease [IBD]. Care for pregnant IBD patients in itself is a complex issue because of the delicate balance between controlling maternal IBD as well as promoting the health of the unborn child. This often requires continued immunosuppressive maintenance medication or the introduction of new IBD medication during pregnancy. The current global COVID-19 pandemic creates an additional challenge in the management of pregnant IBD patients. In this paper we aimed to answer relevant questions that can be encountered in daily clinical practice when caring for pregnant women with IBD during the current COVID-19 pandemic. PODCAST: This article has an associated podcast which can be accessed at https://academic.oup.com/ecco-jcc/pages/podcast Oxford University Press 2020-10-21 /pmc/articles/PMC7665400/ /pubmed/33085970 http://dx.doi.org/10.1093/ecco-jcc/jjaa125 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of European Crohn’s and Colitis Organisation. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Supplement Articles
De Lima-Karagiannis, A
Juillerat, P
Sebastian, S
Pedersen, N
Bar-Gil Shitrit, A
van der Woude, C J
Management of Pregnant Inflammatory Bowel Disease Patients During the COVID-19 Pandemic
title Management of Pregnant Inflammatory Bowel Disease Patients During the COVID-19 Pandemic
title_full Management of Pregnant Inflammatory Bowel Disease Patients During the COVID-19 Pandemic
title_fullStr Management of Pregnant Inflammatory Bowel Disease Patients During the COVID-19 Pandemic
title_full_unstemmed Management of Pregnant Inflammatory Bowel Disease Patients During the COVID-19 Pandemic
title_short Management of Pregnant Inflammatory Bowel Disease Patients During the COVID-19 Pandemic
title_sort management of pregnant inflammatory bowel disease patients during the covid-19 pandemic
topic Supplement Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665400/
https://www.ncbi.nlm.nih.gov/pubmed/33085970
http://dx.doi.org/10.1093/ecco-jcc/jjaa125
work_keys_str_mv AT delimakaragiannisa managementofpregnantinflammatoryboweldiseasepatientsduringthecovid19pandemic
AT juilleratp managementofpregnantinflammatoryboweldiseasepatientsduringthecovid19pandemic
AT sebastians managementofpregnantinflammatoryboweldiseasepatientsduringthecovid19pandemic
AT pedersenn managementofpregnantinflammatoryboweldiseasepatientsduringthecovid19pandemic
AT bargilshitrita managementofpregnantinflammatoryboweldiseasepatientsduringthecovid19pandemic
AT vanderwoudecj managementofpregnantinflammatoryboweldiseasepatientsduringthecovid19pandemic

Ejemplares similares